Close Menu

Within every industry, there's an Apple or a GE, says Luke Timmerman at Xconomy"anchors" or "models of success" that other companies in that industry look up to. In biotech, that role has been filled by companies like Genentech and Genzyme, Timmerman adds, but because of buyouts and mergers in almost every regional cluster, the industry is losing its anchors.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.